EKSO - Ekso Bionics Holdings, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 590.32M
Enterprise Value 378.87M
Trailing P/E N/A
Forward P/E 1-5.79
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)7.27
Price/Book (mrq)18.13
Enterprise Value/Revenue 36.34
Enterprise Value/EBITDA 6-3.90

Trading Information

Stock Price History

Beta (3Y Monthly) 2.66
52-Week Change 3-40.31%
S&P500 52-Week Change 36.70%
52 Week High 33.3000
52 Week Low 31.1200
50-Day Moving Average 31.2806
200-Day Moving Average 31.8601

Share Statistics

Avg Vol (3 month) 3466.75k
Avg Vol (10 day) 3337.41k
Shares Outstanding 560.83M
Float 47.95M
% Held by Insiders 11.68%
% Held by Institutions 138.51%
Shares Short (Jun 28, 2019) 42.64M
Short Ratio (Jun 28, 2019) 46.59
Short % of Float (Jun 28, 2019) 45.66%
Short % of Shares Outstanding (Jun 28, 2019) 43.55%
Shares Short (prior month May 31, 2019) 42.57M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 27/1
Last Split Date 3May 5, 2016

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Mar 31, 2019

Profitability

Profit Margin -206.29%
Operating Margin (ttm)-173.32%

Management Effectiveness

Return on Assets (ttm)-51.97%
Return on Equity (ttm)-264.72%

Income Statement

Revenue (ttm)12.43M
Revenue Per Share (ttm)0.20
Quarterly Revenue Growth (yoy)43.60%
Gross Profit (ttm)4.31M
EBITDA -20.21M
Net Income Avi to Common (ttm)-25.64M
Diluted EPS (ttm)-0.4110
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)9.24M
Total Cash Per Share (mrq)0.14
Total Debt (mrq)5.89M
Total Debt/Equity (mrq)129.82
Current Ratio (mrq)1.73
Book Value Per Share (mrq)0.07

Cash Flow Statement

Operating Cash Flow (ttm)-20.6M
Levered Free Cash Flow (ttm)-10.59M